GCP
COCH icon

GSA Capital Partners’s Envoy Medical COCH Stock Holding History

GSA Capital Partners’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Buy
+12,629
New +$8.61K ﹤0.01% 1657

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM

GSA Capital Partners's COCH Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Envoy Medical (COCH) in Q1 2026: 12,629 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #1657 among its holdings.

33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • GSA Capital Partners held 12,629 shares of Envoy Medical worth $8K as of Q1 2026.
  • Envoy Medical was a new GSA Capital Partners position in Q1 2026.
  • Envoy Medical made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1657 holding.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.